{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:34:56Z","timestamp":1765780496169,"version":"3.48.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>\n                    Canine cognitive dysfunction (CCD) is an age-related neurodegenerative disorder for which effective treatments remain limited, and objective diagnostic and therapeutic assessment tools using biomarkers or neuroimaging are still lacking compared with human Alzheimer\u2019s disease. This study evaluated the safety and efficacy of a long-acting donepezil depot injection in dogs with CCD, using behavioral scores and serum neurofilament light chain (NfL) as primary outcomes, with baseline MRI for diagnostic support. Thirty-two dogs with clinically diagnosed CCD were randomly assigned to a high-dose group (\n                    <jats:italic>n<\/jats:italic>\n                    \u202f=\u202f11), a low-dose group (\n                    <jats:italic>n<\/jats:italic>\n                    \u202f=\u202f11), or a control group (\n                    <jats:italic>n<\/jats:italic>\n                    \u202f=\u202f10). Diagnosis was established based on the Canine Cognitive Dysfunction Rating Scale (CCDR), the CAnine DEmentia Scale (CADES), and DISHAA scoring, and baseline MRI was performed in selected dogs with owner consent. A single intramuscular injection of donepezil depot was administered on day 0, and evaluations were conducted on days 14 and 28. The high-dose group showed significant improvements in CCDR, CADES, and DISHAA at both 14 and 28\u202fdays, whereas the low-dose group improved primarily at day 28, with earlier effects limited to CADES (\n                    <jats:italic>p<\/jats:italic>\n                    \u202f&amp;lt;\u202f0.05). At day 28, both treatment groups had significantly lower serum NfL levels than controls (\n                    <jats:italic>p<\/jats:italic>\n                    \u202f&amp;lt;\u202f0.05), while within-grou\n                    <jats:italic>p<\/jats:italic>\n                    values remained stable. Quality-of-life scores improved in activity, sociability, overall condition, and global QoL. Adverse events were mild and transient. These findings suggest that a single intramuscular injection of long-acting donepezil depot demonstrates favorable safety and potential efficacy in dogs with CCD, with improvements in behavioral scores and NfL supporting its therapeutic potential and highlighting the value of integrating clinical and biomarker-based assessments in future CCD management.\n                  <\/jats:p>","DOI":"10.3389\/fvets.2025.1724060","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:30:19Z","timestamp":1765780219000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the safety and efficacy of a donepezil depot injection in dogs with canine cognitive dysfunction"],"prefix":"10.3389","volume":"12","author":[{"given":"Min-Hee","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Ae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Jung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-chul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don-Gil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Myung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cvsm.2012.04.003","article-title":"Cognitive dysfunction syndrome: a disease of canine and feline brain aging","volume":"42","author":"Landsberg","year":"2012","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cvsm.2019.01.013","article-title":"Canine cognitive dysfunction: pathophysiology, diagnosis, and treatment","volume":"49","author":"Dewey","year":"2019","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2460\/ajvr.25.02.0053","article-title":"Recent advances in diagnostic and therapeutic strategies for canine cognitive dysfunction","volume":"86","author":"Kim","year":"2025","journal-title":"Am J Vet Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/cne.23877","article-title":"Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment","volume":"524","author":"Smolek","year":"2016","journal-title":"J Comp Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"13168","DOI":"10.3390\/ijms222313168","article-title":"A review of the current mammalian models of Alzheimer\u2019s disease and challenges that need to be overcome","volume":"22","author":"McKean","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tvjl.2009.11.007","article-title":"Under diagnosis of canine cognitive dysfunction: a cross-sectional survey of older companion dogs","volume":"184","author":"Salvin","year":"2010","journal-title":"Vet J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"CD001190","DOI":"10.1002\/14651858.CD001190.pub3","article-title":"Donepezil for dementia due to Alzheimer\u2019s disease","volume":"6","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1226200","DOI":"10.3389\/fvets.2023.1125618","article-title":"Potential revival of cholinesterase inhibitors as drugs in veterinary medicine","volume":"10","author":"\u017dnidar\u0161i\u010d","year":"2023","journal-title":"Front Vet Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tvjl.2010.05.014","article-title":"The canine cognitive dysfunction rating scale (CCDR): a data-driven and ecologically relevant assessment tool","volume":"188","author":"Salvin","year":"2011","journal-title":"Vet J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.applanim.2015.08.034","article-title":"Assessment of severity and progression of canine cognitive dysfunction syndrome using the CAnine DEmentia scale (CADES)","volume":"171","author":"Madari","year":"2015","journal-title":"Appl Anim Behav Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2460\/javma.2001.218.1787","article-title":"Prevalence of behavioral changes associated with age-related cognitive impairment in dogs","volume":"218","author":"Neilson","year":"2001","journal-title":"J Am Vet Med Assoc"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1563798","DOI":"10.3389\/fvets.2025.1563798","article-title":"Ischemic brain infarction and cognitive dysfunction syndrome in an aged dog","volume":"12","author":"Kang","year":"2025","journal-title":"Front Vet Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3233\/JAD-2011-110005","article-title":"Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs","volume":"26","author":"Araujo","year":"2011","journal-title":"J Alzheimer's Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"18098","DOI":"10.1038\/s41598-021-97404-2","article-title":"Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor","volume":"11","author":"Zako\u0161ek Pipan","year":"2021","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"165975","DOI":"10.1016\/j.bbadis.2020.165975","article-title":"Donepezil provides neuroprotective effects against brain injury and Alzheimer\u2019s pathology under conditions of cardiac ischemia\/reperfusion injury","volume":"1867","author":"Ongnok","year":"2021","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/life14070839","article-title":"Therapeutic effect of donepezil on neuroinflammation and cognitive impairment after moderate traumatic brain injury","volume":"14","author":"Youn","year":"2024","journal-title":"Life"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s12035-020-01951-0","article-title":"Plasma neurofilament light chain as a translational biomarker of aging and neurodegeneration in dogs","volume":"57","author":"Panek","year":"2020","journal-title":"Mol Neurobiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"13771","DOI":"10.3390\/ijms241813771","article-title":"Plasma neurofilament light chains as blood-based biomarkers for early diagnosis of canine cognitive dysfunction syndrome","volume":"24","author":"Wu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/ani15131974","article-title":"Evaluation of blood-based diagnostic biomarkers for canine cognitive dysfunction syndrome","volume":"15","author":"Yoon","year":"2025","journal-title":"Animals"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.1007\/s11357-025-01822-3","article-title":"Quantifying placebo and trial participation effects on cognitive outcome measures in aging dogs","volume":"47","author":"Simon","year":"2025","journal-title":"GeroScience"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1724060\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:30:20Z","timestamp":1765780220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1724060\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":21,"alternative-id":["10.3389\/fvets.2025.1724060"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2025.1724060","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"1724060"}}